Form 4 holding
CHIEF FINANCIAL OFFICER
Oncotelic Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 358,837
- Estimated value
- $9,330
- Report date
- 08 Jul 2021
- Price
- $0.0260
- Ownership
- Direct
Amit B. Shah
Insider Reports History
- Reporting-owner location
- Aliso Viejo, CA
- Latest reporting-owner signature
- /s/ Amit Shah
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Amit B. Shah
Form 4 holding
CHIEF FINANCIAL OFFICER
Oncotelic Therapeutics, Inc.
- Security class
- Stock Options
- Shares / value
- 698,256
- Estimated value
- Report date
- 08 Jul 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Amit B. Shah
4
OTLC
Oncotelic Therapeutics, Inc.
- Report period
- 08 Jul 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 16 Jul 2021, 17:37
- Role
- CHIEF FINANCIAL OFFICER
- Next action
- Open filing details